<DOC>
	<DOCNO>NCT01652131</DOCNO>
	<brief_summary>There objective evidence long intravenous solution remain inside venous blood vessel administer , therefore definite guideline administer preoperative setting . Besides , obese patient represent particular group subject theoretically with-hold constant inflammatory response would modify way solution behave intravenously , long remain inside . Having say , wish describe way colloid solution behave group patient take serial blood sample 12 obese patient colloid infusion , calculate plasma dilution curve base hemoglobin dilution therefore infer time remain intravascularly . All hope information help , near future , establish objective way use solution avoid possible complication due over-administration .</brief_summary>
	<brief_title>Behaviour Intravenous Solutions Obese Patients Under General Anesthesia</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Obesity , Morbid</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<criteria>clinical diagnosis obesity ( IMC &gt; 35kg/m2 ) treat gastrojejunal laparoscopic bypass Renal failure KDOQI &gt; 3 Cardiac failure NYHA IIIIV Sepsis Allergy tetrastarch Allergy anesthetic medication use protocol previously establish Patients vasoactive drug use Patients blood sample complete .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>general anesthesia</keyword>
	<keyword>volume kinetics</keyword>
</DOC>